BDBM502334 N-{4-[7-(5,6- dimethoxy- 1H-benzo- imidazole-2- yl)-1-methyl- [1,2,4]tri- azolo[4,3- a]quinoxaline- 4-ylamino]- butyl}-3- methyl- butyramide::US11028090, Example 227

SMILES CNc1cc2nc([nH]c2cc1OC)-c1ccc2c(c1)nc(NCCCCNC(=O)CC(C)C)c1nnc(C)n21

InChI Key InChIKey=CLLNLNJFJSCUKR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 502334   

TargetBromodomain-containing protein 4(Homo sapiens (Human))
Dong Wha Pharm.

US Patent
LigandPNGBDBM502334(N-{4-[7-(5,6- dimethoxy- 1H-benzo- imidazole-2- yl...)
Affinity DataIC50:  1nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent